{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T16:11:48Z","timestamp":1794672708100,"version":"4.9.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:00:00Z","timestamp":1673222400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017412","name":"Becton Dickinson and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","gynecologiconcology-online.net","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ygyno.2023.01.004","type":"journal-article","created":{"date-parts":[[2023,1,22]],"date-time":"2023-01-22T08:57:25Z","timestamp":1674377845000},"page":"143-152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Detection of high-grade cervical neoplasia using extended genotyping: Performance data from the longitudinal phase of the Onclarity trial"],"prefix":"10.1016","volume":"170","author":[{"given":"Mark H.","family":"Stoler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Thomas C.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Parvu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Yanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles K.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2023.01.004_bb0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/oxfordjournals.jncimonographs.a003479","article-title":"Chapter 1: human papillomavirus and cervical cancer--burden and assessment of causality","author":"Bosch","year":"2003","journal-title":"J. Natl. Cancer Inst. Monogr."},{"key":"10.1016\/j.ygyno.2023.01.004_bb0010","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/AOG.0b013e3181e4629f","article-title":"From human papillomavirus to cervical cancer","volume":"116","author":"Schiffman","year":"2010","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2023.01.004_bb0015","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J. Pathol."},{"key":"10.1016\/j.ygyno.2023.01.004_bb0020","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jama.2018.7464","article-title":"Effect of screening with primary cervical HPV testing vs cytology testing on high-grade cervical intraepithelial neoplasia at 48 months: the HPV FOCAL randomized clinical trial","volume":"320","author":"Ogilvie","year":"2018","journal-title":"JAMA."},{"key":"10.1016\/j.ygyno.2023.01.004_bb0025","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1470-2045(11)70296-0","article-title":"Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial","volume":"13","author":"Rijkaart","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2023.01.004_bb0030","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet."},{"key":"10.1016\/j.ygyno.2023.01.004_bb0035","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ygyno.2014.11.076","article-title":"Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test","volume":"136","author":"Wright","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2023.01.004_bb0040","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1309\/AJCPTGD94EVRSJCG","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"137","author":"Saslow","year":"2012","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.ygyno.2023.01.004_bb0045","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/14737159.2017.1293525","article-title":"Molecular tests potentially improving HPV screening and genotyping for cervical cancer prevention","volume":"17","author":"Gradissimo","year":"2017","journal-title":"Expert. Rev. Mol. Diagn."},{"key":"10.1016\/j.ygyno.2023.01.004_bb0050","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for cervical cancer: US preventive services task force recommendation statement","volume":"320","author":"Curry","year":"2018","journal-title":"Jama."},{"key":"10.1016\/j.ygyno.2023.01.004_bb0055","author":"American Cancer Society"},{"key":"10.1016\/j.ygyno.2023.01.004_bb0060","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ygyno.2014.12.022","article-title":"Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance","volume":"136","author":"Huh","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2023.01.004_bb0065","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1309\/AJCPTUS5EXAS6DKZ","article-title":"Evaluation of HPV-16 and HPV-18 genotyping for the triage of women with high-risk HPV+ cytology-negative results","volume":"136","author":"Wright","year":"2011","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.ygyno.2023.01.004_bb0070","doi-asserted-by":"crossref","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","article-title":"Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer","volume":"30","author":"Arbyn","year":"2012","journal-title":"Vaccine."},{"key":"10.1016\/j.ygyno.2023.01.004_bb0075","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.ejca.2011.01.008","article-title":"A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: Extended follow up in the ARTISTIC trial","volume":"47","author":"Kitchener","year":"2011","journal-title":"Eur. J. Cancer (Oxford, England: 1990)."},{"key":"10.1016\/j.ygyno.2023.01.004_bb0080","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/bjc.2011.581","article-title":"HPV DNA testing in population-based cervical screening (VUSA-screen study): results and implications","volume":"106","author":"Rijkaart","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2023.01.004_bb0085","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","article-title":"Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial","volume":"11","author":"Ronco","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2023.01.004_bb0090","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/LGT.0000000000000528","article-title":"2019 ASCCP risk-based management consensus guidelines: methods for risk estimation, recommended management, and validation","volume":"24","author":"Cheung","year":"2020","journal-title":"J. Low. Genit. Tract. Dis."},{"key":"10.1016\/j.ygyno.2023.01.004_bb0095","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ygyno.2018.12.024","article-title":"Stratified risk of high-grade cervical disease using onclarity HPV extended genotyping in women, >\/=2 years of age, with NILM cytology","volume":"153","author":"Stoler","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2023.01.004_bb0100","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ygyno.2019.05.012","article-title":"Risk detection for high-grade cervical disease using Onclarity HPV extended genotyping in women, >\/=2 years of age, with ASC-US or LSIL cytology","volume":"154","author":"Wright","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2023.01.004_bb0105","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1158\/1055-9965.EPI-05-0764","article-title":"Human papillomavirus type-specific 18-month risk of high-grade cervical intraepithelial neoplasia in women with a normal or borderline\/mildly dyskaryotic smear","volume":"15","author":"Berkhof","year":"2006","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ygyno.2023.01.004_bb0110","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/bmj.325.7364.572","article-title":"Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study","volume":"325","author":"Kjaer","year":"2002","journal-title":"BMJ (Clinical research ed)."},{"key":"10.1016\/j.ygyno.2023.01.004_bb0115","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ygyno.2015.01.551","article-title":"Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: data from the ATHENA trial","volume":"137","author":"Monsonego","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2023.01.004_bb0120","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/sj.bjc.6603843","article-title":"HPV type-specific risks of high-grade CIN during 4 years of follow-up: a population-based prospective study","volume":"97","author":"Naucler","year":"2007","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2023.01.004_bb0125","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1002\/ijc.30375","article-title":"A cohort study of cervical screening using partial HPV typing and cytology triage","volume":"139","author":"Schiffman","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2023.01.004_bb0130","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/ijc.29085","article-title":"Long-term HPV type-specific risks of high-grade cervical intraepithelial lesions: a 14-year follow-up of a randomized primary HPV screening trial","volume":"136","author":"Smelov","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2023.01.004_bb0135","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ijc.29374","article-title":"Long-term risk of cervical intraepithelial neoplasia grade 3 or worse according to high-risk human papillomavirus genotype and semi-quantitative viral load among 33,288 women with normal cervical cytology","volume":"137","author":"Thomsen","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2023.01.004_bb0140","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/ijc.28605","article-title":"The influence of type-specific human papillomavirus infections on the detection of cervical precancer and cancer: a population-based study of opportunistic cervical screening in the United States","volume":"135","author":"Wheeler","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2023.01.004_bb0145","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/LGT.0000000000000531","article-title":"An introduction to the 2019 ASCCP risk-based management consensus guidelines","volume":"24","author":"Schiffman","year":"2020","journal-title":"J. Lower Genital Tract Dis."},{"key":"10.1016\/j.ygyno.2023.01.004_bb0150","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ygyno.2018.04.007","article-title":"The Onclarity human papillomavirus trial: design, methods, and baseline results","volume":"149","author":"Stoler","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2023.01.004_bb0155","series-title":"Statistical Analysis with Missing Data","author":"Little","year":"2002"},{"key":"10.1016\/j.ygyno.2023.01.004_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/LGT.0000000000000494","article-title":"Clinical utility of human papillomavirus genotyping in cervical cancer screening: a systematic review","volume":"24","author":"Bonde","year":"2020","journal-title":"J. Low. Genit. Tract. Dis."},{"key":"10.1016\/j.ygyno.2023.01.004_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2016.10.042","article-title":"Management of women with human papillomavirus persistence: long-term follow-up of a randomized clinical trial","volume":"216","author":"Elfgren","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2023.01.004_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/cea59317-929c-464a-b3f7-e095248f229a","article-title":"Natural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study","volume":"8","author":"Jaisamrarn","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2023.01.004_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta18230","article-title":"The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds","volume":"18","author":"Kitchener","year":"2014","journal-title":"Health Technol. Assess."},{"key":"10.1016\/j.ygyno.2023.01.004_bb0180","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1093\/jnci\/djq356","article-title":"Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence","volume":"102","author":"Kjaer","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2023.01.004_bb0185","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1002\/ijc.31883","article-title":"Risk of CIN3 or worse with persistence of 13 individual oncogenic HPV types","volume":"144","author":"Sand","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2023.01.004_bb0190","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.virol.2005.04.002","article-title":"The carcinogenicity of human papillomavirus types reflects viral evolution","volume":"337","author":"Schiffman","year":"2005","journal-title":"Virology."},{"key":"10.1016\/j.ygyno.2023.01.004_bb0195","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jnci\/dji187","article-title":"The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice","volume":"97","author":"Khan","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2023.01.004_bb0200","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/jnci\/djq001","article-title":"Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2\/3: critical role of duration of infection","volume":"102","author":"Rodriguez","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2023.01.004_bb0205","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/LGT.0000000000000573","article-title":"Human Papillomavirus Same Genotype Persistence and Risk: A Systematic Review","volume":"25","author":"Bonde","year":"2021","journal-title":"J. Low. Genit. Tract. Dis."},{"key":"10.1016\/j.ygyno.2023.01.004_bb0210","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/LGT.0000000000000685","article-title":"Risk-based cervical consensus guidelines: methods to determine management if less than 5 years of data are available","volume":"26","author":"Egemen","year":"2022","journal-title":"J. Low. Genit. Tract. Dis."},{"key":"10.1016\/j.ygyno.2023.01.004_bb0215","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1080\/14760584.2022.2129615","article-title":"Real-world impact and effectiveness of the quadrivalent HPV vaccine: an updated systematic literature review","volume":"21","author":"Wang","year":"2022","journal-title":"Exp. Rev. Vaccines."},{"key":"10.1016\/j.ygyno.2023.01.004_bb0220","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/ijc.33033","article-title":"Association of HPV35 with cervical carcinogenesis among women of African ancestry: evidence of viral-host interaction with implications for disease intervention","volume":"147","author":"Pinheiro","year":"2020","journal-title":"Int. J. Cancer"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825823000045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825823000045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:50:19Z","timestamp":1715820619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825823000045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":44,"alternative-id":["S0090825823000045"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2023.01.004","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detection of high-grade cervical neoplasia using extended genotyping: Performance data from the longitudinal phase of the Onclarity trial","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2023.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}